I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 16% ± 0% | |
| GABAergic neuron | 3 studies | 19% ± 2% | |
| glutamatergic neuron | 3 studies | 40% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 16% ± 0% | |
| GABAergic neuron | 3 studies | 19% ± 2% | |
| glutamatergic neuron | 3 studies | 40% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 471.52 | 243 / 245 | 100% | 7.98 | 501 / 502 |
| ovary | 99% | 1118.93 | 179 / 180 | 99% | 10.57 | 424 / 430 |
| breast | 99% | 370.19 | 454 / 459 | 98% | 9.86 | 1093 / 1118 |
| brain | 98% | 554.55 | 2585 / 2642 | 96% | 5.13 | 677 / 705 |
| esophagus | 100% | 795.77 | 1440 / 1445 | 94% | 9.65 | 172 / 183 |
| thymus | 100% | 1093.14 | 652 / 653 | 93% | 12.77 | 563 / 605 |
| kidney | 100% | 317.24 | 89 / 89 | 90% | 8.38 | 811 / 901 |
| lung | 93% | 421.82 | 535 / 578 | 95% | 13.18 | 1102 / 1155 |
| intestine | 99% | 707.92 | 954 / 966 | 89% | 4.25 | 470 / 527 |
| uterus | 100% | 844.06 | 170 / 170 | 88% | 7.04 | 403 / 459 |
| bladder | 100% | 448.38 | 21 / 21 | 87% | 6.43 | 437 / 504 |
| stomach | 100% | 702.45 | 359 / 359 | 86% | 4.42 | 247 / 286 |
| adrenal gland | 97% | 332.21 | 251 / 258 | 77% | 5.06 | 177 / 230 |
| liver | 95% | 199.26 | 214 / 226 | 79% | 7.41 | 320 / 406 |
| pancreas | 97% | 408.68 | 317 / 328 | 76% | 3.40 | 136 / 178 |
| skin | 67% | 192.79 | 1210 / 1809 | 55% | 2.24 | 259 / 472 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.16 | 1 / 1 |
| blood vessel | 98% | 417.37 | 1313 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 95% | 352.62 | 1144 / 1204 | 0% | 0 | 0 / 0 |
| heart | 95% | 391.65 | 815 / 861 | 0% | 0 | 0 / 0 |
| spleen | 85% | 166.74 | 204 / 241 | 0% | 0 | 0 / 0 |
| muscle | 83% | 210.18 | 663 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 3.91 | 37 / 45 |
| eye | 0% | 0 | 0 / 0 | 34% | 1.31 | 27 / 80 |
| peripheral blood | 18% | 35.84 | 164 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZSCAN31 |
| Protein name | Zinc finger and SCAN domain-containing protein 31 (Zinc finger protein 323) Zinc finger and SCAN domain containing 31 |
| Synonyms | ZNF323 ZNF310P |
| Description | FUNCTION: May function as a transcription factor. May be involved in the development of multiple embryonic organs. |
| Accessions | ENST00000426434.1 C9JIC2 ENST00000453745.5 ENST00000439628.5 C9JBH3 ENST00000396838.6 [Q96LW9-1] ENST00000439158.5 [Q96LW9-1] ENST00000344279.11 [Q96LW9-1] ENST00000434036.5 C9JH14 Q96LW9 C9IYT1 ENST00000447021.1 ENST00000435857.5 ENST00000414429.5 [Q96LW9-1] C9JHB1 C9J423 ENST00000444081.5 ENST00000446474.5 [Q96LW9-2] C9J1X2 ENST00000446222.5 ENST00000426756.5 C9JPM5 C9JAI0 ENST00000611469.4 [Q96LW9-2] ENST00000414431.1 C9JUE1 ENST00000439636.5 C9J6S7 |
